Core-Shell Nanocomposites for Targeted Raman-Guided Cancer Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nano-sized systems for cancer diagnosis and treatment lack multifunctional, tunable characteristics such as controllable surface chemistry, stability in liquid environments, non-toxicity, and the ability to generate unique and intense signals for high-resolution detection and delivery of drugs to cancer cells.
Innovation Solution
The use of plasmonically active silver-decorated gold nanorods (AuNR/Ag) conjugated with doxorubicin and anti-EpCAM or Docetaxel antibodies, along with Raman spectroscopic properties, for targeted drug delivery and detection of cancer cells, utilizing a multitude of drug delivery vehicles with different antibodies and Raman scattering molecules for accurate determination and detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional nanoparticles are used for drug delivery, then they can deliver drugs to target cells, but they lack multifunctional characteristics including controllable surface chemistry, stability in liquid environments, and ability to generate unique detection signals
Solution Approach 1:
The patent employs core-shell structured nanocomposites where a gold nanorod core provides structural stability and plasmonic properties, while a silica shell provides chemical inertness and surface functionality. This composite structure simultaneously achieves multifunctionality (drug delivery, imaging, targeting) and reliability (stability in biological environments), resolving the technical contradiction between adaptability and reliability.
2Adaptability or versatility
If nanoparticles are functionalized with multiple agents for targeted delivery and detection, then they gain multifunctional capabilities, but their structural complexity increases
Solution Approach 1:
The nanocomposite design integrates multiple functions into a single platform: the gold nanorod core provides photothermal therapy capability and structural stability, the silica shell enables surface functionalization for drug loading and targeting, and the overall structure supports both imaging and therapeutic functions. This universal design achieves multifunctionality without proportionally increasing structural complexity, as all functions are integrated into one cohesive nanosystem rather than requiring separate components.
3Productivity
If high concentrations of drugs are delivered to cancer cells, then treatment efficacy is enhanced, but toxicity to healthy cells may increase
Solution Approach 1:
The patent segments the drug delivery function from the targeting function by using a modular nanocomposite structure where drugs are loaded in the silica shell while targeting antibodies are conjugated to the gold nanorod surface. This segmentation allows precise control over drug release at the target site, enabling high local concentration for efficacy while minimizing systemic toxicity to healthy cells through targeted delivery and controlled release mechanisms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables specific targeting and visualization of cancer cells and tumors while delivering anti-cancer molecules, enhancing cancer treatment efficacy through synergistic drug delivery and providing unique Raman signatures for detection and quantification.
Implementation Method 1
plasmonically active silver-decorated gold nanorods (AuNR/Ag) as specific targeting dual drug delivery system... provide unique and strong signals to enable their accurate detection inside cells
Implementation Method 2
plasmonically active silver-decorated gold nanorods... ability to generate unique and intense signals that can be detected with high resolution in tissues
Implementation Method 3
anti-EpCAM (Ab1) and Docetaxel (D2) and anti-CD44 (Ab2) antibodies are covalently bound to thiolated polyethylene glycol-coated AuNR/Ag and then used as a vehicle to specifically trace and deliver lethal doses of chemotherapy
Data Source
AI summary
A nanoagent for detections and treatments of multiple targets of interest includes multiple types of nanocomposites, each type of nanocomposites comprising at least one nanostructure, each nanostructure having a core and a shell surrounding the core; a respective reporter assembled on the shell of each nanostructure; and a layer of a respective treating agent and a respective targeting agent conjugated to the respective reporter. In use, each type of nanocomposite targets to a respective target of interest according to the respective targeting agent and releases the respective treating agent and the nanostructure therein for therapeutic treatment of the respective target of interest, and the respective target of interest transmits at least one signature responsive to the respective reporter for detection of the respective target of interest.